Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-650-3649975
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Dextera Surgical (NASDAQ:DXTR) Frequently Asked Questions
What is Dextera Surgical's stock symbol?
Dextera Surgical trades on the NASDAQ under the ticker symbol "DXTR."
How were Dextera Surgical's earnings last quarter?
Dextera Surgical Inc (NASDAQ:DXTR) released its quarterly earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The medical instruments supplier had revenue of $0.69 million for the quarter, compared to analysts' expectations of $0.62 million. View Dextera Surgical's Earnings History.
Has Dextera Surgical been receiving favorable news coverage?
Media coverage about DXTR stock has trended positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Dextera Surgical earned a daily sentiment score of 2.7 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term.
What other stocks do shareholders of Dextera Surgical own?
Who are Dextera Surgical's key executives?
Dextera Surgical's management team includes the folowing people:
- Robert Y. Newell IV, Principal Executive Officer, Chief Financial Officer, Vice President - Finance (Age 67)
- Michael A. Bates, Director (Age 57)
- Julian Nikolchev, Director (Age 62)
How do I buy shares of Dextera Surgical?
Shares of DXTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dextera Surgical's official website?
How can I contact Dextera Surgical?
Dextera Surgical's mailing address is 900 Saginaw Dr, REDWOOD CITY, CA 94063-4753, United States. The medical instruments supplier can be reached via phone at +1-650-3649975 or via email at [email protected]
MarketBeat Community Rating for Dextera Surgical (NASDAQ DXTR)
MarketBeat's community ratings are surveys of what our community members think about Dextera Surgical and other stocks. Vote "Outperform" if you believe DXTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
